retatrutide benefits clinical trial retatrutide FDA Approval Status 2026: Everything We Know So Far What Is Retatrutide? | Peptide

2008;51(suppl 1):S356

These benefits may be attributed to improved glycemic control, weight loss, reduced inflammation, and direct effects on blood vessels and the heart

Changes in Fluid Balance: These medications can affect fluid balance in the body, which may result in drier stools

At 2.4mg weekly, semaglutide produces roughly 15% total body weight reduction, translating to about 37 pounds for the same 248-pound person

GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise

Trimi covers most of these points in its published materials